X-pand – A biotech company

X-pand – A biotech company

TAVI

TAVI
xpand

Transapical Transcatheter Aortic Valve
Implantation System

What is TAVI or TAVR ?

TAVI or TAVR stands for transcatheter aortic
valve implantation or replacement.

This is a minimally invasive procedure that allows inserting a new valve without removing the old, diseased valve. The new valve is placed inside the old valve which is unable to function properly and in many cases requires replacement.

The collapsible new valve is delivered through a catheter (a thin wire or tube) – such an approach is somewhat similar to placing a stent in the artery. Once the new valve is delivered to the implantation site, it expands and pushes the old valve leaflets out. The new valve then takes over the job of regulating the blood flow.

Ergonomic Design

The TAVI XPAND valve consists of an external Dacron cuff that supports the platform configuration. 

LEAFLETS

Bovine pericardium

CUFF

DACRON

STENT

Self-expanding nitinol

STERILIZATION

Chemical

STORAGE SOLUTION

TLS

STORAGE TEMPERATURE

5 ℃ – 25 ℃

What is involved in the procedure?

1

Valve replacement usually requires open-heart surgery, in which the chest is surgically separated. Alternatively, the TAVR (or TAVI) procedure can be done through very small openings making the procedure less invasive.

2

Patients usually need less time for postoperative recovery after the TAVI procedure compared to valve replacement when using open-heart surgery.

3

The TAVI procedure can be performed using several protocols/techniques, allowing the interventional cardiac surgeon to choose the one that would provide the best and safest way to access the valve.

4

While TAVI is not without certain risks, it allows surgical treatment options to people who are not considered candidates for valve replacement using open-heart surgery for a variety of reasons

Special Features of TAVI XPAND™ Delivery System

Who will benefit from TAVI?

The TAVI procedure has demonstrated to be alternative effective in patients with symptomatic severe aortic stenosis in all risk categories (low, moderate or high) for valve replacement using standard open-heart surgery.

No need to stop the heart or use cardiopulmonary bypass for the procedure

Minimal risk of infection

Minimal injury to the chest and the heart muscle

Shorter hospital stay

Quicker time of postoperative recovery

Ability to resume daily activities and get back to your normal life faster

The TAVI procedure has demonstrated to be rather effective in patients with symptomatic severe aortic stenosis in all risk categories (low, moderate or high) for valve replacement using standard open-heart surgery.